TACE Combined With Lenvatinib and PD-1 Inhibitor for Ruptured Hepatocellular Carcinoma
Clinical trial NCT06740370 · RECRUITING
Trial details
- NCT number
- NCT06740370
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-13
- Primary completion
- 2025-12-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.